VIA Pharmaceuticals, Inc.

OTCPK:VIAP Stock Report

Market Cap: US$20.0

VIA Pharmaceuticals Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure17.6yrs

Recent management updates

No updates

Recent updates

No updates

CEO

VIA Pharmaceuticals has no CEO, or we have no data on them.

Board Members

NamePositionTenureCompensationOwnership
Thomas Quertermous
Chief Scientific Officer & Member of Scientific Advisory Boardno datano datano data
Frederick Craves
Director17.6yrsno datano data
David Howard
Independent Director17.6yrsUS$38.50kno data
John Larson
Director21.9yrsUS$25.00kno data
Jean Tardif
Member of Clinical Advisory Boardno datano datano data
Peter Libby
Member of Clinical Advisory Boardno datano datano data
Christopher Glass
Scientific Advisorno datano datano data
Jean-Lucien Rouleau
Member of Clinical Advisory Boardno datano datano data
Colin Funk
Scientific Advisorno datano datano data
Marc Pfeffer
Chair of Clinical Advisory Boardno datano datano data
Israel Charo
Scientific Advisorno datano datano data
Robert Fenichel
Member of Clinical Advisory Boardno datano datano data

17.6yrs

Average Tenure

74yo

Average Age

Experienced Board: VIAP's board of directors are seasoned and experienced ( 17.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/04 07:05
End of Day Share Price 2024/12/30 00:00
Earnings2010/12/31
Annual Earnings2010/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

VIA Pharmaceuticals, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution